Clinical Trial Update: Pilot Study of 18F-FAZA in Assessing Early Functional Response in Patients With Inoperable Non Small Cell Lung Cancer Undergoing Radiotherapy or Chemo-radiotherapy

View source ↗

Summary

A pilot study evaluates the use of the PET tracer 18F-FAZA to assess early functional response in patients with inoperable non-small cell lung cancer undergoing…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• 18F-FAZA (fluorine-18 labeled nitroimidazole PET radiotracer)

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Lung Neoplasm, Cell Hypoxia | Status: UNKNOWN